Header Logo

Connection

Charles Quesenberry to Estrogens

This is a "connection" page, showing publications Charles Quesenberry has written about Estrogens.
Connection Strength

0.526
  1. Venous thromboembolic disease in users of low-estrogen combined estrogen-progestin oral contraceptives. Contraception. 2004 Jul; 70(1):3-10.
    View in: PubMed
    Score: 0.237
  2. Myocardial infarction and the use of estrogen and estrogen-progestogen in postmenopausal women. Ann Intern Med. 1997 Oct 01; 127(7):501-8.
    View in: PubMed
    Score: 0.149
  3. Current use of unopposed estrogen and estrogen plus progestin and the risk of acute myocardial infarction among women with diabetes: the Northern California Kaiser Permanente Diabetes Registry, 1995-1998. Circulation. 2003 Jan 07; 107(1):43-8.
    View in: PubMed
    Score: 0.054
  4. Ischemic stroke and use of estrogen and estrogen/progestogen as hormone replacement therapy. Stroke. 1998 Jan; 29(1):23-8.
    View in: PubMed
    Score: 0.038
  5. Recent combined hormonal contraceptives (CHCs) and the risk of thromboembolism and other cardiovascular events in new users. Contraception. 2013 Jan; 87(1):93-100.
    View in: PubMed
    Score: 0.026
  6. Timing of hormone therapy and dementia: the critical window theory revisited. Ann Neurol. 2011 Jan; 69(1):163-9.
    View in: PubMed
    Score: 0.023

© 2024 Kaiser Permanente